Manufacturing and Production

Showing 15 posts of 5866 posts found.

18538_700x200

Navigating CMC Requirements during drug development and post-approval

April 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dia

This training will offer you the overview of the existing regulatory aspects of the CMC, and will also give you …
hans-bishop_2x

Juno CEO and Co-founder steps down in wake of Celgene acquisition

April 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Juno, appointment, pharma

Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …
john_reed

Sanofi makes ex-Roche scientist new R&D chief

April 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Sanofi, appointment, pharma

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …
becca

Health to hand

April 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Breast Cancer Care, biotech, drugs, pharma, pharmaceutical

Kristina Barrick is the Digital Innovation Manager at Breast Cancer Care and leads on the development of BECCA, the Breast …

MHRA bans sodium valproate in the UK following birth defect controversy

April 24, 2018 Manufacturing and Production, Research and Development, Sales and Marketing MHRA, Sanofi, Sodium valproate, bipolar, epilepsy, pharma

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced that sodium valproate, a drug used in the treatment …

Lilly’s arthritis drug hits trouble at FDA committee

April 24, 2018 Manufacturing and Production, Sales and Marketing Eli Lilly, Incyte, biotech, drugs, pharma, pharmaceutical, rheumatoid arthritis

FDA’s advisory committee were openly conflicted about deciding on the safety of Eli Lilly and Incyte’s drug, baricitinib, for the …
astrazeneca_logo_building

AZ’s combo woes continue, with failure in lung cancer

April 24, 2018 Manufacturing and Production, Research and Development AstraZeneca, Imfinzi, biotech, drugs, pharma, pharmaceutical

AstraZeneca has been hit by a fresh blow in its search for an immunotherapy combination treatment that could differentiate it …
prothena-37882-2

Prothena collapses on double trial failure

April 23, 2018 Manufacturing and Production, Research and Development Prothena Therapeutics, biotech, drugs, pharma, pharmaceutical

Shares in Prothena have dropped by close to 70% on the news that two of its trials into its lead …
tony_green_edit

Living with atrial fibrillation

April 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing KardiaMobile, Tony Green, atrial fibrillation, patient experience

Tony Green discusses the difficulty in pinning down his diagnosis of the irregular heart rhythm condition, until his use of …
top_ten

Top Ten most popular articles on Pharmafile.com this week

April 20, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, EMA, GW Pharma, J&J, JJ, MHRA, Mylan, Novartis, Sanofi, Shire, Takeda, biotech, drugs, epipen, keytruda, pharma, pharmaceutical

It’s the end of another week and there’s really been one story that has dominated the headlines – Takeda’s potential …
shutterstock_244903099

The UK’s Royalties withholding tax consultation: Pushing extraterritorial boundaries

April 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Norton Rose Fulbright, feature, pharma, tax consultation

Norton Rose Fulbright’s Dominic Stuttaford, James Baillieu and Susie Brain discuss the implications regarding the recent reforms to cross-border royalties.The …
iannone

Immunomedics’ whirlwind in the C-suite continues

April 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, …
bill_chin_headshot

Frequency Therapeutics hires industry vet

April 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, …
The Gateway to Local Adoption Series

Latest content